{"id":102100,"date":"2026-09-01T13:03:48","date_gmt":"2026-09-01T11:03:48","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?post_type=resources&p=102100"},"modified":"2026-09-01T13:01:07","modified_gmt":"2026-09-01T11:01:07","slug":"veeva-falcon-safety-to-work-with-all-e2b-compliant-safety-systems-across-any-intake-channels","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/eu\/resources\/veeva-falcon-safety-to-work-with-all-e2b-compliant-safety-systems-across-any-intake-channels\/","title":{"rendered":"³Ô¹Ï±¬ÁÏ Falcon Safety to Work with All E2B-Compliant Safety Systems Across Any Intake Channels"},"content":{"rendered":"

PLEASANTON, CA \u2014 Sept. 1, 2026 \u2014<\/strong> ³Ô¹Ï±¬ÁÏ Systems<\/a> (NYSE: VEEV) today announced ³Ô¹Ï±¬ÁÏ Falcon Safety, an agentic safety operations product to streamline adverse event intake, case processing, and follow-up to reduce costs, increase speed, and maintain compliance for biopharma companies of all sizes.<\/p>\n

\nIn addition to working seamlessly with ³Ô¹Ï±¬ÁÏ Safety<\/a>, Falcon Safety will provide intake and follow-up management for any E2B-compliant safety system, including Oracle Argus and ArisGlobal LifeSphere MultiVigilance.\n<\/p>\n

\n“We\u2019ve had the privilege of working closely with case processors, pharmacovigilance experts, and safety specialists globally to build ³Ô¹Ï±¬ÁÏ Safety,” said Marius Mortensen, vice president of product, Falcon at ³Ô¹Ï±¬ÁÏ. “With Falcon Safety, we\u2019re excited to build on that partnership to help the industry reinvent safety operations.”\n<\/p>\n

\nPlanned for early adopter availability in November 2026, Falcon Safety is part of ³Ô¹Ï±¬ÁÏ AI, ³Ô¹Ï±¬ÁÏ\u2019s industry-specific AI solutions for life sciences.\n<\/p>\n

About ³Ô¹Ï±¬ÁÏ Systems<\/strong>
\n³Ô¹Ï±¬ÁÏ delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,500 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation<\/a>, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com\/eu<\/a>.\n<\/p>\n

³Ô¹Ï±¬ÁÏ Forward-Looking Statements
\nThis release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the fiscal year ended July 31, 2026, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.\n<\/p>\n

###<\/center><\/p>\n

\nContact:<\/strong>\n<\/p>\n

\nJeremy Whittaker
\n³Ô¹Ï±¬ÁÏ Systems, Europe
\njeremy.whittaker@veeva.com<\/a>\n<\/p>\n

Elizabeth McGrane
\n³Ô¹Ï±¬ÁÏ Systems
\nelizabeth.mcgrane@veeva.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

³Ô¹Ï±¬ÁÏ announces Falcon Safety, an agentic safety operations product to streamline adverse event intake, case processing, and follow-up.<\/p>\n","protected":false},"featured_media":102126,"parent":0,"template":"","class_list":["post-102100","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-area-20-safety","resource-product-20-safety2","resource-type-news-press-release","resource-type-press-release"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t